NCT04771728View on ClinicalTrials.gov

A Prospective, Randomized Controlled Study of the Probiotics as Adjuvant Treatment for Bacterial Vaginosis

PHASE4RecruitingINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

February 1, 2020

Primary Completion Date

December 1, 2026

Study Completion Date

December 1, 2026

Conditions
Bacterial Vaginosis
Interventions
DRUG

Metronidazole vaginal suppositories

Metronidazole vaginal suppositories (200 mg,2 capsules per day,7 days )

DRUG

Metronidazole vaginal suppositories and Probiotics(Umeta-mimi)

Metronidazole vaginal suppositories (200 mg,2 capsules per day,7 days ) and Oral pobiotics(Umeta-mimi,5×109cfu per day,30 days）

Trial Locations (1)

518036

RECRUITING

Peking University Shenzhen Hosptal, Shenzhen

All Listed Sponsors
collaborator

BGI, China

OTHER

lead

Peking University Shenzhen Hospital

OTHER